Global AI in Drug Discovery Market
Artificial Intelligence / AI in Drug Discovery Research Report 2023 - Global Forecast to 2028: Market to Grow by $4 Billion, at a CAGR of 40.2%
27 févr. 2024 03h18 HE | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence / AI in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead Generation, Optimization), Drug Design...
Research Nester Logo.jpg
Proteomics Market revenue to surpass USD 144.7 Billion by 2035, says Research Nester
26 févr. 2024 05h00 HE | Research Nester
New York, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The global proteomics market size is projected to grow at a CAGR of over ~13.68% from 2023 to 2035. The market is expected to garner a revenue of USD...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Life-Science Analytics Market Size is Expected to Surpass the USD 20.9 Billion By 2033; CAGR of 8.0%
12 févr. 2024 07h54 HE | Market.Us
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Life-Science Analytics Market size is projected to exceed USD 20.9 Billion by 2033, and it is poised to reach a...
22157.jpg
Therapeutic Drug Monitoring Market Experiencing Robust Growth, Bolstered by Advanced Healthcare IT Integration - Global Trends, Opportunity, and Forecast, 2018-2028F
08 févr. 2024 09h33 HE | Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Yiviva and AstraZeneca Strategic Collaboration Memorandum Signing Ceremony
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach
05 févr. 2024 09h00 HE | Yiviva
NEW YORK and SHANGHAI, China, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed...
DMPK for Press Release
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
01 févr. 2024 04h30 HE | SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Feb. 01, 2024 (GLOBE NEWSWIRE) -- To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global...
Global Orphan Drugs Market
Global Orphan Drugs Research Analysis Report 2023: Growing Approvals of Innovative Orphan Drugs Propel Market Expansion, Biologics Lead the Way - Forecasts to 2034
31 janv. 2024 11h22 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drugs Market Analysis & Forecast 2024-2034: Market By Drug Type; By Therapy; By Distribution Channel; and By Region" report has been...
22157.jpg
Pharmacovigilance Aspects of Licensing Agreements: 1-Day Online Training Course (July 10th, 2024)
31 janv. 2024 07h09 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Aspects of Licensing Agreements Training Course" conference has been added to ResearchAndMarkets.com's offering. Whilst licensing...
22157.jpg
2 Day Virtual Variations to Marketing Authorisations Training Course
31 janv. 2024 04h47 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Variations to Marketing Authorisations Training Course" conference has been added to ResearchAndMarkets.com's offering. It is a key post-marketing...
22157.jpg
Imutex's FLU-v Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: Focus on United States,Germany, France, Italy, Spain, United Kingdom, and Japan
31 janv. 2024 04h06 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "FLU-v Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...